These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18310184)

  • 1. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination.
    Jackson LA; Starkovich P; Dunstan M; Yu O; Nelson J; Dunn J; Rees T; Zavitkovsky A; Maus D; Froeschle JE; Decker M
    Pediatrics; 2008 Mar; 121(3):e646-52. PubMed ID: 18310184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
    J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis vaccination: a randomized, controlled trial.
    Jackson LA; Dunstan M; Starkovich P; Dunn J; Yu O; Nelson JC; Rees T; Zavitkovsky A
    Pediatrics; 2006 Mar; 117(3):620-5. PubMed ID: 16510639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
    Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD
    Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length.
    Ipp MM; Gold R; Goldbach M; Maresky DC; Saunders N; Greenberg S; Davy T
    Pediatrics; 1989 May; 83(5):679-82. PubMed ID: 2717284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose.
    Rennels MB; Black S; Woo EJ; Campbell S; Edwards KM
    Pediatr Infect Dis J; 2008 May; 27(5):464-5. PubMed ID: 18398385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children.
    Marshall HS; Gold MS; Gent R; Quinn PJ; Piotto L; Clarke MF; Roberton DM
    Pediatrics; 2006 Oct; 118(4):1501-9. PubMed ID: 17015541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study.
    Carbone T; McEntire B; Kissin D; Kelly D; Steinschneider A; Violaris K; Karamchandani N
    Pediatrics; 2008 May; 121(5):e1085-90. PubMed ID: 18450851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands.
    Bults M; Kemmeren JM; van der Maas NA
    Vaccine; 2007 Jul; 25(29):5272-7. PubMed ID: 17573165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children.
    Bose A; Dubey AP; Gandhi D; Pandit A; Raghu MB; Raghupathy P; Rao MI; Verghese VP; Datta SK; Bock HL
    Indian Pediatr; 2007 Jun; 44(6):421-4. PubMed ID: 17620694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection site and risk of medically attended local reactions to acellular pertussis vaccine.
    Jackson LA; Yu O; Nelson JC; Dominguez C; Peterson D; Baxter R; Hambidge SJ; Naleway AL; Belongia EA; Nordin JD; Baggs J;
    Pediatrics; 2011 Mar; 127(3):e581-7. PubMed ID: 21300679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants.
    Shek LP; Khor ES; Tan GH; Low KT; Ong D; Roy J; Han HH; Bock HL; Lee BW
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):863-8. PubMed ID: 15115101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old.
    Quinn P; Gold M; Royle J; Buttery J; Richmond P; McIntyre P; Wood N; Lee SS; Marshall H
    Vaccine; 2011 Jun; 29(25):4230-7. PubMed ID: 21497629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.